Decreased cAMP in Asthmatic Airway Smooth Muscle
Author Information
Author(s): Trian Thomas, Burgess Janette K., Niimi Kyoko, Moir Lyn M., Ge Qi, Berger Patrick, Liggett Stephen B., Black Judith L., Oliver Brian G.
Primary Institution: Woolcock Institute of Medical Research, The University of Sydney
Hypothesis
Increased PDE4D in asthmatic airway smooth muscle contributes to the β2AR defect observed in asthma.
Conclusion
Asthmatic airway smooth muscle has decreased β-agonist induced cAMP due to increased PDE4D expression, leading to impaired bronchodilation.
Supporting Evidence
- Asthmatic ASM had ∼50% lower cAMP production in response to β-agonists compared to non-asthmatic ASM.
- Inhibition of PDE4 normalized cAMP production in asthmatic ASM.
- PDE4D expression was found to be ∼2-fold greater in asthmatic ASM compared to non-asthmatic ASM.
Takeaway
People with asthma have a problem with a chemical called cAMP that helps their airways relax, making it harder for them to breathe. This problem is caused by a higher level of an enzyme that breaks down cAMP.
Methodology
The study compared cAMP production in cultured airway smooth muscle cells from asthmatic and non-asthmatic subjects, measuring PDE activity and expression.
Potential Biases
Potential bias in patient selection and the influence of medications on cell behavior.
Limitations
The study was limited to cultured cells and may not fully represent in vivo conditions.
Participant Demographics
15 asthmatic and 22 non-asthmatic subjects were included.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website